Showing results (351-360 of 465) with videos related to
Sort By:
Pageof 47
Antiviral Research|July 11, 2013
A treatment for and vaccine against the deadly Hendra and Nipah virusesChristopher C Broder, Kai Xu, Dimitar B Nikolov, et al.Journal of Virology|November 8, 2013
Exceptionally potent and broadly cross-reactive, bispecific multivalent HIV-1 inhibitors based on single human CD4 and antibody domainsWeizao Chen, Yang Feng, Ponraj Prabakaran, et al.Journal of Virology|June 7, 2002
Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediatesHana Golding, Marina Zaitseva, Eve de Rosny, et al.Cell Reports|December 16, 2021
Structural analysis of receptor binding domain mutations in SARS-CoV-2 variants of concern that modulate ACE2 and antibody bindingDhiraj Mannar, James W Saville, Xing Zhu, et al.IJU Case Reports|August 4, 2020
Bladder urothelial carcinoma producing insulin-like growth factor II: A case reportSatoshi Funada, Yuki Kita, Yoshiyuki Okada, et al.Scientific Reports|August 20, 2016
Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus InfectionAnurodh Shankar Agrawal, Tianlei Ying, Xinrong Tao, et al.Plos One|May 27, 2015
Identification of Non-HIV Immunogens That Bind to Germline b12 Predecessors and Prime for Elicitation of Cross-clade Neutralizing HIV-1 AntibodiesZheng Yang, Jingjing Li, Qingsheng Liu, et al.Translational Oncology|November 12, 2021
Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cellsNayanendu Saha, Kai Xu, Zhongyu Zhu, et al.Mabs|April 14, 2018
N-terminal α-amino group modification of antibodies using a site-selective click chemistry methodDe-Zhi Li, Bing-Nan Han, Rui Wei, et al.International Journal of Biological Sciences|June 19, 2018
A dual-specific IGF-I/II human engineered antibody domain inhibits IGF signaling in breast cancer cellsZhizhen Chen, Jie Liu, Dafeng Chu, et al.Pageof 47